Anti-inflammatory effect of pelubiprofen, 2-[4-(oxocyclohexylidenemethyl)-phenyl]propionic acid, mediated by dual suppression of COX activity and LPS-induced inflammatory gene expression via NF-κB inactivation

Pelubiprofen is a non‐steroidal anti‐inflammatory drugs (NSAIDs) that is related both structurally and pharmacologically to ibuprofen. Anti‐inflammatory properties of ibuprofen are due to its ability to both decrease prostaglandin synthesis by inhibiting the activities of cyclooxygenases (COXs) and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular biochemistry 2011-12, Vol.112 (12), p.3594-3603
Hauptverfasser: Shin, Ji-Sun, Baek, Seung Ryel, Sohn, Se-il, Cho, Young-wuk, Lee, Kyung-Tae
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3603
container_issue 12
container_start_page 3594
container_title Journal of cellular biochemistry
container_volume 112
creator Shin, Ji-Sun
Baek, Seung Ryel
Sohn, Se-il
Cho, Young-wuk
Lee, Kyung-Tae
description Pelubiprofen is a non‐steroidal anti‐inflammatory drugs (NSAIDs) that is related both structurally and pharmacologically to ibuprofen. Anti‐inflammatory properties of ibuprofen are due to its ability to both decrease prostaglandin synthesis by inhibiting the activities of cyclooxygenases (COXs) and IκB kinase‐β (IKK‐β). However, the exact mechanisms that accounts for the anti‐inflammatory effects of pelubiprofen are not reported. In this study, we investigated the molecular mechanisms how pelubiprofen modulates the inflammatory mediators in LPS‐induced macrophages and carrageenan‐induced acute inflammatory rat model. Pelubiprofen potently diminished PGE2 productions through inhibition of COX enzyme activity (IC50 values for COX‐1 and COX‐2 are 10.66 ± 0.99 and 2.88 ± 1.01 µM, respectively), but also reduced the expressions of COX‐2, inducible nitric oxide (iNOS), tumor necrosis factor‐α (TNF‐α), interleukin‐1β (IL‐1β), and IL‐6 at transcriptional level in LPS‐induced RAW 264.7 cells. In addition, pelubiprofen attenuated the LPS‐induced transcription activity and the DNA binding activity of NF‐κB, which was accompanied by a parallel reduction of degradation and phosphorylation of inhibitory kappa B‐α (IκB‐α) and consequently by decreased nuclear translocation of NF‐κB. Furthermore, pelubipofen inhibited the LPS‐induced phosphorylation of IKK‐β and transforming growth factor‐β activated kinase‐1 (TAK1). In acute inflammatory rat model, pretreatment with pelubiprofen inhibited carrageenan‐induce edema, neutrophil migration, PGE2 production, and p65, a subunit of NF‐κB, nuclear translocation in inflamed paw. Taken together, our data indicated that pelubiprofen is involved in the dual inhibition of COX activity and TAK1‐IKK‐NF‐κB pathway, revealing molecular basis for the anti‐inflammatory properties of pelubiprofen. J. Cell. Biochem. 112: 3594–3603, 2011. © 2011 Wiley Periodicals, Inc.
doi_str_mv 10.1002/jcb.23290
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_900641016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>900641016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3620-af9d0b5bee4965f54a11678826938e1a5da0e6012e9364284ebbcc973d1312cb3</originalsourceid><addsrcrecordid>eNp1kctu1DAUhiMEokNhwQsg76BS3fqSOPGyHdEBNL0IikBCyHKcE8bFuRA7ZfJqPAQLngi3047EgtWRjr7_P5c_SZ5TckAJYYdXpjxgnEnyIJlRInOcijR9mMxIzglmnLKd5In3V4QQKTl7nOwwWhDJczZL_hy1wWLb1k43jQ7dMCGoazABdTXqwY2l7YeuhnYfMfwlxa-6dWcm47oVrCdnK2ihgbCa3B7uV9BO7mvEe9u11iBtbLWPGqisDlChckLVqB3yY98P4H2EbobMzz9HMthrGyak2wotLz7EharRRM0_i32LwxCst-Jrq9HZCf796zhytxY6xP7T5FGtnYdnd3U3-Xjy-nL-Bi_PF2_nR0tsuGAE61pWpMxKgFSKrM5STanIi4IJyQugOqs0AUEoA8lFyooUytIYmfOKxo-aku8mLze-8eIfI_igGusNOKdb6EavJCEipYSKSO5tSDN03g9Qq36wjR4mRYm6SVDFBNVtgpF9cec6lvF1W_I-sggcboCf1sH0fyf1bn58b4k3CusDrLcKPXxXIud5pj6dLdQpfV8sTy8W6pL_BdC0uYk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>900641016</pqid></control><display><type>article</type><title>Anti-inflammatory effect of pelubiprofen, 2-[4-(oxocyclohexylidenemethyl)-phenyl]propionic acid, mediated by dual suppression of COX activity and LPS-induced inflammatory gene expression via NF-κB inactivation</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Shin, Ji-Sun ; Baek, Seung Ryel ; Sohn, Se-il ; Cho, Young-wuk ; Lee, Kyung-Tae</creator><creatorcontrib>Shin, Ji-Sun ; Baek, Seung Ryel ; Sohn, Se-il ; Cho, Young-wuk ; Lee, Kyung-Tae</creatorcontrib><description>Pelubiprofen is a non‐steroidal anti‐inflammatory drugs (NSAIDs) that is related both structurally and pharmacologically to ibuprofen. Anti‐inflammatory properties of ibuprofen are due to its ability to both decrease prostaglandin synthesis by inhibiting the activities of cyclooxygenases (COXs) and IκB kinase‐β (IKK‐β). However, the exact mechanisms that accounts for the anti‐inflammatory effects of pelubiprofen are not reported. In this study, we investigated the molecular mechanisms how pelubiprofen modulates the inflammatory mediators in LPS‐induced macrophages and carrageenan‐induced acute inflammatory rat model. Pelubiprofen potently diminished PGE2 productions through inhibition of COX enzyme activity (IC50 values for COX‐1 and COX‐2 are 10.66 ± 0.99 and 2.88 ± 1.01 µM, respectively), but also reduced the expressions of COX‐2, inducible nitric oxide (iNOS), tumor necrosis factor‐α (TNF‐α), interleukin‐1β (IL‐1β), and IL‐6 at transcriptional level in LPS‐induced RAW 264.7 cells. In addition, pelubiprofen attenuated the LPS‐induced transcription activity and the DNA binding activity of NF‐κB, which was accompanied by a parallel reduction of degradation and phosphorylation of inhibitory kappa B‐α (IκB‐α) and consequently by decreased nuclear translocation of NF‐κB. Furthermore, pelubipofen inhibited the LPS‐induced phosphorylation of IKK‐β and transforming growth factor‐β activated kinase‐1 (TAK1). In acute inflammatory rat model, pretreatment with pelubiprofen inhibited carrageenan‐induce edema, neutrophil migration, PGE2 production, and p65, a subunit of NF‐κB, nuclear translocation in inflamed paw. Taken together, our data indicated that pelubiprofen is involved in the dual inhibition of COX activity and TAK1‐IKK‐NF‐κB pathway, revealing molecular basis for the anti‐inflammatory properties of pelubiprofen. J. Cell. Biochem. 112: 3594–3603, 2011. © 2011 Wiley Periodicals, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.23290</identifier><identifier>PMID: 21809372</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; Base Sequence ; Blotting, Western ; Cyclooxygenase ; Cyclooxygenase Inhibitors - pharmacology ; Cytokines ; DNA Primers ; Electrophoretic Mobility Shift Assay ; Gene Expression Regulation - drug effects ; Inhibitory Concentration 50 ; Lipopolysaccharides - pharmacology ; NF-kappa B - antagonists &amp; inhibitors ; Nitric oxide ; Nuclear factor-κB ; Paw EDEMA ; Pelubiprofen ; Rats ; Reverse Transcriptase Polymerase Chain Reaction</subject><ispartof>Journal of cellular biochemistry, 2011-12, Vol.112 (12), p.3594-3603</ispartof><rights>Copyright © 2011 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3620-af9d0b5bee4965f54a11678826938e1a5da0e6012e9364284ebbcc973d1312cb3</citedby><cites>FETCH-LOGICAL-c3620-af9d0b5bee4965f54a11678826938e1a5da0e6012e9364284ebbcc973d1312cb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcb.23290$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcb.23290$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21809372$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shin, Ji-Sun</creatorcontrib><creatorcontrib>Baek, Seung Ryel</creatorcontrib><creatorcontrib>Sohn, Se-il</creatorcontrib><creatorcontrib>Cho, Young-wuk</creatorcontrib><creatorcontrib>Lee, Kyung-Tae</creatorcontrib><title>Anti-inflammatory effect of pelubiprofen, 2-[4-(oxocyclohexylidenemethyl)-phenyl]propionic acid, mediated by dual suppression of COX activity and LPS-induced inflammatory gene expression via NF-κB inactivation</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>Pelubiprofen is a non‐steroidal anti‐inflammatory drugs (NSAIDs) that is related both structurally and pharmacologically to ibuprofen. Anti‐inflammatory properties of ibuprofen are due to its ability to both decrease prostaglandin synthesis by inhibiting the activities of cyclooxygenases (COXs) and IκB kinase‐β (IKK‐β). However, the exact mechanisms that accounts for the anti‐inflammatory effects of pelubiprofen are not reported. In this study, we investigated the molecular mechanisms how pelubiprofen modulates the inflammatory mediators in LPS‐induced macrophages and carrageenan‐induced acute inflammatory rat model. Pelubiprofen potently diminished PGE2 productions through inhibition of COX enzyme activity (IC50 values for COX‐1 and COX‐2 are 10.66 ± 0.99 and 2.88 ± 1.01 µM, respectively), but also reduced the expressions of COX‐2, inducible nitric oxide (iNOS), tumor necrosis factor‐α (TNF‐α), interleukin‐1β (IL‐1β), and IL‐6 at transcriptional level in LPS‐induced RAW 264.7 cells. In addition, pelubiprofen attenuated the LPS‐induced transcription activity and the DNA binding activity of NF‐κB, which was accompanied by a parallel reduction of degradation and phosphorylation of inhibitory kappa B‐α (IκB‐α) and consequently by decreased nuclear translocation of NF‐κB. Furthermore, pelubipofen inhibited the LPS‐induced phosphorylation of IKK‐β and transforming growth factor‐β activated kinase‐1 (TAK1). In acute inflammatory rat model, pretreatment with pelubiprofen inhibited carrageenan‐induce edema, neutrophil migration, PGE2 production, and p65, a subunit of NF‐κB, nuclear translocation in inflamed paw. Taken together, our data indicated that pelubiprofen is involved in the dual inhibition of COX activity and TAK1‐IKK‐NF‐κB pathway, revealing molecular basis for the anti‐inflammatory properties of pelubiprofen. J. Cell. Biochem. 112: 3594–3603, 2011. © 2011 Wiley Periodicals, Inc.</description><subject>Animals</subject><subject>Base Sequence</subject><subject>Blotting, Western</subject><subject>Cyclooxygenase</subject><subject>Cyclooxygenase Inhibitors - pharmacology</subject><subject>Cytokines</subject><subject>DNA Primers</subject><subject>Electrophoretic Mobility Shift Assay</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Inhibitory Concentration 50</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>NF-kappa B - antagonists &amp; inhibitors</subject><subject>Nitric oxide</subject><subject>Nuclear factor-κB</subject><subject>Paw EDEMA</subject><subject>Pelubiprofen</subject><subject>Rats</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctu1DAUhiMEokNhwQsg76BS3fqSOPGyHdEBNL0IikBCyHKcE8bFuRA7ZfJqPAQLngi3047EgtWRjr7_P5c_SZ5TckAJYYdXpjxgnEnyIJlRInOcijR9mMxIzglmnLKd5In3V4QQKTl7nOwwWhDJczZL_hy1wWLb1k43jQ7dMCGoazABdTXqwY2l7YeuhnYfMfwlxa-6dWcm47oVrCdnK2ihgbCa3B7uV9BO7mvEe9u11iBtbLWPGqisDlChckLVqB3yY98P4H2EbobMzz9HMthrGyak2wotLz7EharRRM0_i32LwxCst-Jrq9HZCf796zhytxY6xP7T5FGtnYdnd3U3-Xjy-nL-Bi_PF2_nR0tsuGAE61pWpMxKgFSKrM5STanIi4IJyQugOqs0AUEoA8lFyooUytIYmfOKxo-aku8mLze-8eIfI_igGusNOKdb6EavJCEipYSKSO5tSDN03g9Qq36wjR4mRYm6SVDFBNVtgpF9cec6lvF1W_I-sggcboCf1sH0fyf1bn58b4k3CusDrLcKPXxXIud5pj6dLdQpfV8sTy8W6pL_BdC0uYk</recordid><startdate>201112</startdate><enddate>201112</enddate><creator>Shin, Ji-Sun</creator><creator>Baek, Seung Ryel</creator><creator>Sohn, Se-il</creator><creator>Cho, Young-wuk</creator><creator>Lee, Kyung-Tae</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201112</creationdate><title>Anti-inflammatory effect of pelubiprofen, 2-[4-(oxocyclohexylidenemethyl)-phenyl]propionic acid, mediated by dual suppression of COX activity and LPS-induced inflammatory gene expression via NF-κB inactivation</title><author>Shin, Ji-Sun ; Baek, Seung Ryel ; Sohn, Se-il ; Cho, Young-wuk ; Lee, Kyung-Tae</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3620-af9d0b5bee4965f54a11678826938e1a5da0e6012e9364284ebbcc973d1312cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Base Sequence</topic><topic>Blotting, Western</topic><topic>Cyclooxygenase</topic><topic>Cyclooxygenase Inhibitors - pharmacology</topic><topic>Cytokines</topic><topic>DNA Primers</topic><topic>Electrophoretic Mobility Shift Assay</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Inhibitory Concentration 50</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>NF-kappa B - antagonists &amp; inhibitors</topic><topic>Nitric oxide</topic><topic>Nuclear factor-κB</topic><topic>Paw EDEMA</topic><topic>Pelubiprofen</topic><topic>Rats</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shin, Ji-Sun</creatorcontrib><creatorcontrib>Baek, Seung Ryel</creatorcontrib><creatorcontrib>Sohn, Se-il</creatorcontrib><creatorcontrib>Cho, Young-wuk</creatorcontrib><creatorcontrib>Lee, Kyung-Tae</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shin, Ji-Sun</au><au>Baek, Seung Ryel</au><au>Sohn, Se-il</au><au>Cho, Young-wuk</au><au>Lee, Kyung-Tae</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-inflammatory effect of pelubiprofen, 2-[4-(oxocyclohexylidenemethyl)-phenyl]propionic acid, mediated by dual suppression of COX activity and LPS-induced inflammatory gene expression via NF-κB inactivation</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2011-12</date><risdate>2011</risdate><volume>112</volume><issue>12</issue><spage>3594</spage><epage>3603</epage><pages>3594-3603</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>Pelubiprofen is a non‐steroidal anti‐inflammatory drugs (NSAIDs) that is related both structurally and pharmacologically to ibuprofen. Anti‐inflammatory properties of ibuprofen are due to its ability to both decrease prostaglandin synthesis by inhibiting the activities of cyclooxygenases (COXs) and IκB kinase‐β (IKK‐β). However, the exact mechanisms that accounts for the anti‐inflammatory effects of pelubiprofen are not reported. In this study, we investigated the molecular mechanisms how pelubiprofen modulates the inflammatory mediators in LPS‐induced macrophages and carrageenan‐induced acute inflammatory rat model. Pelubiprofen potently diminished PGE2 productions through inhibition of COX enzyme activity (IC50 values for COX‐1 and COX‐2 are 10.66 ± 0.99 and 2.88 ± 1.01 µM, respectively), but also reduced the expressions of COX‐2, inducible nitric oxide (iNOS), tumor necrosis factor‐α (TNF‐α), interleukin‐1β (IL‐1β), and IL‐6 at transcriptional level in LPS‐induced RAW 264.7 cells. In addition, pelubiprofen attenuated the LPS‐induced transcription activity and the DNA binding activity of NF‐κB, which was accompanied by a parallel reduction of degradation and phosphorylation of inhibitory kappa B‐α (IκB‐α) and consequently by decreased nuclear translocation of NF‐κB. Furthermore, pelubipofen inhibited the LPS‐induced phosphorylation of IKK‐β and transforming growth factor‐β activated kinase‐1 (TAK1). In acute inflammatory rat model, pretreatment with pelubiprofen inhibited carrageenan‐induce edema, neutrophil migration, PGE2 production, and p65, a subunit of NF‐κB, nuclear translocation in inflamed paw. Taken together, our data indicated that pelubiprofen is involved in the dual inhibition of COX activity and TAK1‐IKK‐NF‐κB pathway, revealing molecular basis for the anti‐inflammatory properties of pelubiprofen. J. Cell. Biochem. 112: 3594–3603, 2011. © 2011 Wiley Periodicals, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>21809372</pmid><doi>10.1002/jcb.23290</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0730-2312
ispartof Journal of cellular biochemistry, 2011-12, Vol.112 (12), p.3594-3603
issn 0730-2312
1097-4644
language eng
recordid cdi_proquest_miscellaneous_900641016
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Animals
Base Sequence
Blotting, Western
Cyclooxygenase
Cyclooxygenase Inhibitors - pharmacology
Cytokines
DNA Primers
Electrophoretic Mobility Shift Assay
Gene Expression Regulation - drug effects
Inhibitory Concentration 50
Lipopolysaccharides - pharmacology
NF-kappa B - antagonists & inhibitors
Nitric oxide
Nuclear factor-κB
Paw EDEMA
Pelubiprofen
Rats
Reverse Transcriptase Polymerase Chain Reaction
title Anti-inflammatory effect of pelubiprofen, 2-[4-(oxocyclohexylidenemethyl)-phenyl]propionic acid, mediated by dual suppression of COX activity and LPS-induced inflammatory gene expression via NF-κB inactivation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T02%3A09%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-inflammatory%20effect%20of%20pelubiprofen,%202-%5B4-(oxocyclohexylidenemethyl)-phenyl%5Dpropionic%20acid,%20mediated%20by%20dual%20suppression%20of%20COX%20activity%20and%20LPS-induced%20inflammatory%20gene%20expression%20via%20NF-%CE%BAB%20inactivation&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Shin,%20Ji-Sun&rft.date=2011-12&rft.volume=112&rft.issue=12&rft.spage=3594&rft.epage=3603&rft.pages=3594-3603&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.23290&rft_dat=%3Cproquest_cross%3E900641016%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=900641016&rft_id=info:pmid/21809372&rfr_iscdi=true